KAIST Partners with Harvard University and Moderna to Train Physician-Scientists and Other Professionals

On the 28th (local time), KAIST signed an MOU with Moderna in Boston, USA, to train medical science professionals. From the left, Kwang Hyung Lee, President of KAIST; Young Lee, Minister of SMEs and Startups; Alpha Gerei, Chief Commercial Officer of Moderna. (Photo by Ministry of SMEs and Startups)

Korea Advanced Institute of Science and Technology (KAIST) is partnering with Harvard University’s Massachusetts General Hospital (hereinafter Mass General Hospital) and the biotech company Moderna to train physician-scientists and bio-specialized personnel.

KAIST announced on the 29th that it signed a memorandum of understanding (MOU) with Mass General Hospital and Moderna at the Langham Hotel in Boston, USA.

Through this MOU, KAIST plans to seek collaboration with the innovative ecosystem created by the convergence of medicine and engineering in the United States. It intends to develop a Korean-style convergence education program and implement a differentiated curriculum by strengthening science and engineering fields such as artificial intelligence (AI) when establishing a graduate school of science, technology, and medicine in the future.

The MOU with Moderna includes training medical science professionals together with KAIST’s Graduate School of Medical Science and Engineering. They will discuss multifaceted cooperation plans covering vaccine and new drug development, virus research, messenger ribonucleic acid (mRNA) joint research, and rapid technology commercialization.

This content was produced with the assistance of AI translation services.